In this online CME self-learning program:
Inflammatory bowel disease (IBD) is a broad term that includes many different forms of inflammatory bowel conditions, the most common of which are Crohn’s disease and ulcerative colitis, the former of which affects any area of the alimentary canal. There are up to about fifteen new Crohn’s disease cases per 100,000 people per year, with the vast majority occurring in the North American continent, the United Kingdom (UK), and northern Europe.
Given the data from multiple studies that physicians are either not aware of updated practice guidelines or are not utilizing them and that this lack of knowledge is affecting patient satisfaction, CME programs are warranted to keep HCPs abreast of best practices. There have been many advances on both diagnostic and treatment sides, as well as a wide array of advances in care in pharmacotherapeutic options, including approved therapies as well as potential ones on the horizon, meriting CME.
Healthcare professionals specializing in: gastroenterology, internal medicine, or those who otherwise commonly care for patients with Crohn’s disease.
This program is supported by an educational grant from AMGEN
Release Date: September 06, 2016 -- Expiration Date: September 06, 2018
Faculty: Aline Charabaty, MD
By the end of the session the participant will be able to:
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Faculty Disclosure: Aline Charabaty, MD, Associate Professor of Medicine Director of the IBD Center MedStar Georgetown University Hospital, discloses financial support (research grant) from Abbvie.
Disclosures of Educational Planners: Charles Turck, PharmD is an officer and part owner of ScientiaCME, LLC.
Commercial Support Disclosure: This program is supported by an educational grant from AMGEN
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.